Second dose of measles-mumps-rubella-varicella vaccine (MMRV) and the risk of febrile convulsions
CONCLUSION: Use of MMRV at second dose is not associated with an increased risk of FC compared to MMR + V or MMR, irrespective of age, sex, history of FC, or type of first dose vaccine.PMID:35232594 | DOI:10.1016/j.vaccine.2022.02.072
Source: Vaccine - Category: Allergy & Immunology Authors: Wiebke Sch äfer Tammo Reinders Tania Schink Source Type: research
More News: Allergy & Immunology | Brain | Children | Databases & Libraries | Germany Health | Measles | Measles Vaccine | MMR (Measles,Mumps,Rubella) Vaccine | Mumps | Mumps Vaccine | Neurology | Rubella | Rubella Vaccine | Study | Vaccines